Literature DB >> 10486703

Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action.

S H Francis1, J D Corbin.   

Abstract

Intracellular cAMP and cGMP levels are increased in response to a variety of hormonal and chemical stimuli; these nucleotides play key roles as second messenger signals in modulating myriad physiological processes. The cAMP-dependent protein kinase and cGMP-dependent protein kinase are major intracellular receptors for these nucleotides, and the actions of these enzymes account for much of the cellular responses to increased levels of cAMP or cGMP. This review summarizes many studies that have contributed significantly to an improved understanding of the catalytic, regulatory, and structural properties of these protein kinases. These accumulated findings provide insights into the mechanisms by which these enzymes produce their specific physiological effects and are helpful in considering the actions of other protein kinases as well.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486703     DOI: 10.1080/10408369991239213

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  78 in total

1.  A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell.

Authors:  T C Rich; K A Fagan; T E Tse; J Schaack; D M Cooper; J W Karpen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.

Authors:  Jun Kotera; Kennard A Grimes; Jackie D Corbin; Sharron H Francis
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

3.  Mechanisms associated with cGMP binding and activation of cGMP-dependent protein kinase.

Authors:  Michael E Wall; Sharron H Francis; Jackie D Corbin; Kennard Grimes; Robyn Richie-Jannetta; Jun Kotera; Brian A Macdonald; Rowena R Gibson; Jill Trewhella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

4.  Probing noncovalent protein-ligand interactions of the cGMP-dependent protein kinase using electrospray ionization time of flight mass spectrometry.

Authors:  Martijn W H Pinkse; Albert J R Heck; Klaus Rumpel; Frank Pullen
Journal:  J Am Soc Mass Spectrom       Date:  2004-10       Impact factor: 3.109

Review 5.  Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.

Authors:  Thérèse Keravis; Claire Lugnier
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 6.  Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment.

Authors:  Isaac Levy; Anelia Horvath; Monalisa Azevedo; Rodrigo Bertollo de Alexandre; Constantine A Stratakis
Journal:  Curr Opin Pharmacol       Date:  2011-10-31       Impact factor: 5.547

Review 7.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

8.  Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3'5' guanosine monophosphate accumulation in retinal pigment epithelium cells.

Authors:  R M H Diederen; E C La Heij; M Markerink-van Ittersum; A Kijlstra; F Hendrikse; J de Vente
Journal:  Br J Ophthalmol       Date:  2006-08-30       Impact factor: 4.638

9.  Severe impairment of growth and differentiation in a Neurospora crassa mutant lacking all heterotrimeric G alpha proteins.

Authors:  Ann M Kays; Katherine A Borkovich
Journal:  Genetics       Date:  2004-03       Impact factor: 4.562

10.  cGMP-dependent protein kinase anchoring by IRAG regulates its nuclear translocation and transcriptional activity.

Authors:  Darren E Casteel; Tong Zhang; Shunhui Zhuang; Renate B Pilz
Journal:  Cell Signal       Date:  2008-03-26       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.